The research and development centre will be closing down over the next two years. Speaking of the closure, Dr Ruth McKernan, the company’s head stated, “It is with a deep sense of sadness that we announce our proposal to exit our site in Sandwich, Kent.
“It has played an important role in the discovery and development of medicines and has brought many life-saving treatments to patients.”
The closure is part of a plan by the pharma company to partake in a global restructuring programme in order to, “to create a more focused and sustainable R&D engine for innovation”.
Are you looking for a new position in the pharmaceutical industry? Click here to search our current pharmaceutical jobs online now.